Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Caladrius Biosciences, Inc.

Caladrius Biosciences (NASDAQ: NBS) is an American biopharmaceutical company active in the field of stem cell therapy and regenerative medicine, particularly of cardiovascular disease. The company was founded in 1980 and was formerly known as Corniche Group Inc, Phase III Medical Inc and NeoStem, Inc. It is headquartered in New York, New York.

Investment goal date:
Dividends reinvested
Caladrius Biosciences, Inc. CLBS report
Period
Date
Adjusted Actuals EPS
GAAP EPS
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BANK OF AMERICA CORP /DE/
540
BlackRock Fund Advisors
1526
BlackRock Inc.
26690
BlackRock Institutional Trust Company, N.A.
24640
FIFTH THIRD BANCORP
1000
GEODE CAPITAL MANAGEMENT, LLC
29432
JACOBS LEVY EQUITY MANAGEMENT, INC
20913
KCG Holdings, Inc.
36291
Knoll Capital Management, LP
117957
MORGAN STANLEY
3532
PANAGORA ASSET MANAGEMENT INC
7173
RENAISSANCE TECHNOLOGIES LLC
97552
UBS Group AG
3281
Vanguard Group, Inc
151217
WELLS FARGO & CO/MN
1950
Major Shareholders
Name Relationship
Total Shares
Holding stocks